TABLE 2.
Timepoint (parameter) | Linezolid (n = 637) | Comparators (n = 611) | Adjusted difference | 95% CI |
---|---|---|---|---|
Baseline | ||||
Mean index | 4.54 ± 2.38 | 4.62 ± 2.64 | −0.06 | −0.33 to 0.21 |
End of treatment | ||||
Mean index | 4.02 ± 2.28 | 5.42 ± 2.45 | −1.43 | −1.68 to −1.17 |
Change from baseline | −0.52 ± 2.52a | 0.80 ± 2.54a | −1.36 | −1.63 to −1.09 |
Follow-up | ||||
Mean index | 5.84 ± 2.89 | 5.65 ± 2.64 | 0.25 | −0.045 to 0.55 |
Change from baseline | 1.29 ± 2.58a | 1.03 ± 2.64a | 0.31 | 0.031 to 0.60 |
Change from baseline within treatment group (P < 0.01).